Epigenetic Aging Clock Predicts Disease and Death Risk in Veterans Over 13 Years
DunedinPACE epigenetic aging measure accurately forecasts chronic disease development, healthcare costs, and mortality in 2,216 veterans.
Summary
Researchers tracked 2,216 post-9/11 veterans for 13 years using DunedinPACE, an epigenetic aging biomarker that measures DNA methylation changes. Veterans with faster biological aging scores developed significantly more chronic diseases and had higher mortality rates. The biomarker predicted 84% increased heart attack risk, 56% higher diabetes risk, and 38% greater overall mortality risk, demonstrating its potential as a clinical tool for early intervention.
Detailed Summary
This groundbreaking study demonstrates that epigenetic aging clocks can serve as powerful predictive tools for real-world health outcomes. Researchers analyzed data from 2,216 post-9/11 veterans enrolled in the VISN 6 MIRECC's Post-Deployment Mental Health Study, using the DunedinPACE biomarker to measure biological aging through DNA methylation patterns.
The study followed veterans for an average of 13.1 years through electronic health records, examining chronic disease development, healthcare costs, and mortality. Veterans with faster DunedinPACE aging scores showed dramatically increased disease risk across multiple timeframes - developing 25% more chronic diseases over 5 years, 31% more over 10 years, and 36% more over 15 years.
The results were striking across specific conditions: 84% increased risk for myocardial infarction, 56% higher diabetes risk, 44% greater liver disease risk, and 34% increased renal disease risk. Healthcare costs also rose significantly with faster aging scores, increasing by 8% over 5 years and 23% over 10 years. Most concerning, faster biological aging predicted 38% higher all-cause mortality and 74% increased chronic disease mortality.
These associations remained robust even after adjusting for demographic factors, biomarkers, and smoking status, suggesting DunedinPACE captures aging processes beyond traditional risk factors. The findings validate epigenetic aging measures as clinically relevant biomarkers that could identify high-risk individuals years before disease onset, enabling earlier interventions and potentially reducing healthcare burden.
Key Findings
- DunedinPACE predicted 25-36% more chronic diseases over 5-15 year periods
- 84% increased heart attack risk and 56% higher diabetes risk with faster aging
- 38% higher all-cause mortality and 74% increased chronic disease deaths
- Healthcare costs rose 8-23% with accelerated epigenetic aging scores
- Associations remained after adjusting for demographics and smoking
Methodology
Longitudinal cohort study of 2,216 post-9/11 veterans followed for average 13.1 years through electronic health records. DunedinPACE epigenetic aging measured from blood DNA methylation patterns, with outcomes including chronic disease incidence, healthcare costs, and mortality.
Study Limitations
Study limited to post-9/11 veterans, potentially limiting generalizability to broader populations. Observational design cannot establish causation between epigenetic aging and health outcomes. Healthcare cost predictions may not reflect actual expenditures.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.